Vertex Pharmaceuticals Incorporated (VX1.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:08AM CEST. Market open.
| Previous close | 411.30 |
| Open | 411.50 |
| Bid | 412.50 x 10000 |
| Ask | 413.70 x 10000 |
| Day's range | 411.50 - 411.50 |
| 52-week range | 299.75 - 420.95 |
| Volume | |
| Avg. volume | 53 |
| Market cap | 106.446B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | 29.00 |
| EPS (TTM) | 14.19 |
| Earnings date | 30 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 258.59 |
GuruFocus.comInsider Sale: CEO & President Reshma Kewalramani Sells 15,202 Shares of Vertex ...
On May 20, 2024, Reshma Kewalramani, CEO & President of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), executed a sale of 15,202 shares of the company, according to the SEC Filing.
Investor's Business DailyStocks Step Back After Fed Minutes; Loar, Monday.com, VRTX In Focus
The 10-year Treasury yield rallied a bit after the minutes from the May 1 Fed meeting were released. Just after the close, the yield was trading around 4.43%, up 2 basis points. Oil and gas stocks lagged badly, along with metals and mining stocks. Loar Holdings followed through after clearing an IPO base Tuesday, while Monday.com is holding gains well...
Business WireVertex to Participate in Upcoming June Investor Conferences
BOSTON, May 22, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences.
© 2024 Yahoo. All rights reserved.